Reaction
Pneumonia Necrotising reporting signals
As of the last recalculation, Pneumonia Necrotising appears in 634 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 48.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 17 | 48.7 | 48.8 |
| Cefepime | 20 | 47.3 | 47.3 |
| Voriconazole Injection | 28 | 44.2 | 44.3 |
| Cefepime Hydrochloride | 20 | 42.0 | 42.1 |
| Alemtuzumab | 22 | 38.7 | 38.7 |
| Valganciclovir Hydrochloride Powder, | 14 | 38.5 | 38.6 |
| Norepinephrine | 12 | 37.5 | 37.6 |
| Voriconazole | 32 | 36.4 | 36.4 |
| Piperacillin Sodium,Tazobactam Sodium | 28 | 36.2 | 36.2 |
| Valganciclovir | 19 | 34.1 | 34.1 |
| Valganciclovir Hydrochloride | 19 | 34.1 | 34.1 |
| Piperacillin And Tazobactam | 13 | 34.0 | 34.1 |
| Oseltamivir | 8 | 33.4 | 33.4 |
| Pegaspargase | 12 | 32.8 | 32.8 |
| Amphotericin B | 12 | 32.0 | 32.1 |
| Micafungin Sodium | 8 | 31.4 | 31.4 |
| Linezolid | 26 | 29.9 | 29.9 |
| Piperacillin Sodium And Tazobactam Sodium | 17 | 29.2 | 29.2 |
| Meropenem | 27 | 28.8 | 28.8 |
| Norepinephrine Bitartrate | 12 | 27.9 | 27.9 |
| Remdesivir | 11 | 27.6 | 27.6 |
| Ceftriaxone | 25 | 26.0 | 26.0 |
| Vincristine Sulfate | 22 | 25.5 | 25.5 |
| Daptomycin | 7 | 25.2 | 25.2 |
| Ceftriaxone Sodium | 27 | 24.1 | 24.1 |
| Vancomycin | 39 | 23.5 | 23.6 |
| Vancomycin Hydrochloride | 43 | 22.9 | 22.9 |
| Mycophenilic Acid | 13 | 21.0 | 21.0 |
| Baricitinib | 6 | 20.6 | 20.6 |
| Oseltamivir Phosphate | 10 | 13.6 | 13.6 |
| Axicabtagene Ciloleucel | 4 | 13.4 | 13.4 |
| Vigabatrin | 4 | 9.1 | 9.1 |